+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Randomized prospective study comparing low-dose OKT3 of low-dose antithymocyte globulins for treatment of the first acute rejection of kidney allografts



Randomized prospective study comparing low-dose OKT3 of low-dose antithymocyte globulins for treatment of the first acute rejection of kidney allografts



Nephrology Dialysis Transplantation 11(6): A276




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033081526

Download citation: RISBibTeXText


Related references

Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Transplantation Proceedings 26(1): 273-274, 1994

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transplant International 11(3): 231-236, 1998

High or low dose steroid therapy for acute renal transplant rejection after prophylactic Okt3 treatment: a prospective randomized study. Transplant International 5: S437-S439, 1992

High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study. Transplant International 5(Suppl. 1): S437-S439, 1992

A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants. Transplantation 69(11): 2374-2381, 2000

Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients. Transplantation Proceedings 25(4): 2574, 1993

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 71(1): 53-58, 2001

Treatment of acute rejection crisis by antilymphocyte globulins: a randomized prospective study in pediatric kidney transplantation. Transplantation Proceedings 19(1 Pt 3): 1886-1888, 1987

A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results. Transplantation Proceedings 32(2): 429-431, 2000

Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation. Transplantation Proceedings 30(4): 1552-1554, 1998

Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy. Transplantation Proceedings 25(1 Pt 1): 550-552, 1993

Rapid anti rejection response and mild first dose reaction with a new monoclonal antibody t10b9 compared to standard anti cd3 treatment okt3 in a prospective double blind randomized trial. Journal of Urology 145(4 Suppl.): 346A, 1991

A prospective comparison of murine monoclonal cd 3 okt3 antibody based and equine antithymocyte globulin based rejection prophylaxis in cardiac transplantation decreased rejection and less corticosteroid use with okt3. Transplantation 47(4): 599-605, 1989

A prospective randomized trial comparing combination half dose tpa with streptokinase to full dose tpa in acute myocardial infarction preliminary report. Journal of the American College of Cardiology 15(2 Suppl. A): 4A, 1990

Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 59(11): 1564-1568, 1995